Sengmany, K., Singh, J., Stewart, G. D., Conn, P. J., Christopoulos, A., & Gregory, K. J. (2016). Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery. Neuropharmacology.

Sengmany, Kathy, Junaid Singh, Gregory D. Stewart, P. Jeffrey Conn, Arthur Christopoulos, and Karen J. Gregory. "Biased Allosteric Agonism and Modulation of Metabotropic Glutamate Receptor 5: Implications for Optimizing Preclinical Neuroscience Drug Discovery." Neuropharmacology 2016.

Sengmany, Kathy, et al. "Biased Allosteric Agonism and Modulation of Metabotropic Glutamate Receptor 5: Implications for Optimizing Preclinical Neuroscience Drug Discovery." Neuropharmacology 2016.